Literature DB >> 1986255

Characterization of the mouse transforming growth factor-beta 1 promoter and activation by the Ha-ras oncogene.

A G Geiser1, S J Kim, A B Roberts, M B Sporn.   

Abstract

We have cloned and sequenced a mouse genomic transforming growth factor beta 1 (TGF-beta 1) DNA fragment that includes the 5' untranslated and regulatory regions of the gene. High-sequence homology with the human TGF-beta 1 gene (66% nucleotide identity in 2.7 kb of DNA upstream of the translational start site) suggested evolutionary conservation of transcriptional regulation for TGF-beta 1. The absence of TATA or CAAT box sequences but the presence of several Sp1-binding and AP-2-like sequences in the promoter region was noted, as previously reported for the human gene. Two transcriptional initiation sites separated by 290 bp were identified by S1 nuclease analysis; these corresponded to transcripts with 866 and 576 nucleotides of 5' untranslated leader sequence. S1 analysis of different mouse tissues indicated that the two transcripts were present in the same ratio even though the total level of TGF-beta 1 mRNA transcripts varied between tissues. Promoter activity adjacent to both transcriptional start sites was demonstrated by using chloramphenicol acetyltransferase fusion genes assayed in mouse AKR-2B fibroblast cells. Transcriptional activation of the promoter by the Ha-ras oncogene was also demonstrated. The minimal promoter constructs (113 and 104 bp 5' of the first and second transcriptional start sites, respectively) were sufficient for induction by Ha-ras. These studies characterize the 5' structure and basal promoter activity of the mouse TGF-beta 1 gene as well as the transcriptional activation of TGF-beta 1 by the Ha-ras oncogene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1986255      PMCID: PMC359593          DOI: 10.1128/mcb.11.1.84-92.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  Characterization of the promoter region of the human transforming growth factor-beta 1 gene.

Authors:  S J Kim; A Glick; M B Sporn; A B Roberts
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

2.  Regulation of a metallothionein-rasT24 fusion gene by zinc results in graded alterations in cell morphology and growth.

Authors:  V L Reynolds; R M Lebovitz; S Warren; T S Hawley; A K Godwin; M W Lieberman
Journal:  Oncogene       Date:  1987       Impact factor: 9.867

3.  Complementary deoxyribonucleic acid cloning of a messenger ribonucleic acid encoding transforming growth factor beta 4 from chicken embryo chondrocytes.

Authors:  S B Jakowlew; P J Dillard; M B Sporn; A B Roberts
Journal:  Mol Endocrinol       Date:  1988-12

4.  cDNA cloning of porcine transforming growth factor-beta 1 mRNAs. Evidence for alternate splicing and polyadenylation.

Authors:  P Kondaiah; E Van Obberghen-Schilling; R L Ludwig; R Dhar; M B Sporn; A B Roberts
Journal:  J Biol Chem       Date:  1988-12-05       Impact factor: 5.157

5.  Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation.

Authors:  L Braun; J E Mead; M Panzica; R Mikumo; G I Bell; N Fausto
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

6.  Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor.

Authors:  R F Tucker; G D Shipley; H L Moses; R W Holley
Journal:  Science       Date:  1984-11-09       Impact factor: 47.728

7.  Retinoic acid induces transforming growth factor-beta 2 in cultured keratinocytes and mouse epidermis.

Authors:  A B Glick; K C Flanders; D Danielpour; S H Yuspa; M B Sporn
Journal:  Cell Regul       Date:  1989-11

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells.

Authors:  E Van Obberghen-Schilling; N S Roche; K C Flanders; M B Sporn; A B Roberts
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

10.  A Harvey-ras responsive transcription element is also responsive to a tumour-promoter and to serum.

Authors:  J L Imler; C Schatz; C Wasylyk; B Chatton; B Wasylyk
Journal:  Nature       Date:  1988-03-17       Impact factor: 49.962

View more
  30 in total

1.  Dopamine, dopamine D2 receptor short isoform, transforming growth factor (TGF)-beta1, and TGF-beta type II receptor interact to inhibit the growth of pituitary lactotropes.

Authors:  D K Sarkar; K Chaturvedi; S Oomizu; N I Boyadjieva; C P Chen
Journal:  Endocrinology       Date:  2005-06-16       Impact factor: 4.736

2.  Allelic diversity in the TGFB1 regulatory region: characterization of novel functional single nucleotide polymorphisms.

Authors:  Riddhish Shah; Brad Rahaman; Carolyn Katovich Hurley; Phillip E Posch
Journal:  Hum Genet       Date:  2005-12-14       Impact factor: 4.132

3.  Differential regulation of cyclooxygenase-2 in nontransformed and ras-transformed intestinal epithelial cells.

Authors:  Jianguo Du; Bo Jiang; John Barnard
Journal:  Neoplasia       Date:  2005-08       Impact factor: 5.715

4.  Transforming growth factor-β3 (TGF-β3) knock-in ameliorates inflammation due to TGF-β1 deficiency while promoting glucose tolerance.

Authors:  Bradford E Hall; Umesh D Wankhade; Joanne E Konkel; Karthik Cherukuri; Chandrasekharam N Nagineni; Kathleen C Flanders; Praveen R Arany; Wanjun Chen; Sushil G Rane; Ashok B Kulkarni
Journal:  J Biol Chem       Date:  2013-09-20       Impact factor: 5.157

5.  Regulation of adhesion and growth of fibrosarcoma cells by NF-kappa B RelA involves transforming growth factor beta.

Authors:  J R Perez; K A Higgins-Sochaski; J Y Maltese; R Narayanan
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

6.  A GC-rich domain with bifunctional effects on mRNA and protein levels: implications for control of transforming growth factor beta 1 expression.

Authors:  L Scotto; R K Assoian
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

7.  Transformation by oncogenic Ras expands the early genomic response to transforming growth factor beta in intestinal epithelial cells.

Authors:  Carl E Allen; Jianguo Du; Bo Jiang; Qin Huang; Adam J Yakovich; John A Barnard
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

8.  A novel mechanism of Ha-ras oncogene action: regulation of fibronectin mRNA levels by a nuclear posttranscriptional event.

Authors:  L A Chandler; C P Ehretsmann; S Bourgeois
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

9.  Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta.

Authors:  G Wolf; E Mueller; R A Stahl; F N Ziyadeh
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

10.  Interferon-alpha inhibits murine macrophage transforming growth factor-beta mRNA expression.

Authors:  S Dhanani; M Huang; J Wang; S M Dubinett
Journal:  Inflammation       Date:  1994-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.